<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药明康德 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-18T11:11:28+08:00</updated>
  <subtitle>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>权威榜单：2020年值得关注的10家初创公司来了！</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/pSJh8si_r1v6e7CiKYuZsQ</id>
    <link href="https://mp.weixin.qq.com/s/pSJh8si_r1v6e7CiKYuZsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿诺医药CEO路杨先生：创新和差异化并举，将癌症变成一种非致命疾病！</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/6XfO_QUg4C2DmJifWogjWg</id>
    <link href="https://mp.weixin.qq.com/s/6XfO_QUg4C2DmJifWogjWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 长效HIV预防新药获FDA突破性疗法认定，优于标准疗法66%</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/2TFlAGuDbRb4JNitlo4ozw</id>
    <link href="https://mp.weixin.qq.com/s/2TFlAGuDbRb4JNitlo4ozw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 2.6亿欧元开发免疫疾病创新疗法，罗氏达成研发合作</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/hpxTuW6XWr51Eweqv6owOw</id>
    <link href="https://mp.weixin.qq.com/s/hpxTuW6XWr51Eweqv6owOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA局长发表声明，致力维护COVID-19紧急使用授权（EUA）的透明度</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/HyckOgOyLurP-5NMQiostg</id>
    <link href="https://mp.weixin.qq.com/s/HyckOgOyLurP-5NMQiostg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>解开衰老密码，《自然》子刊同期两篇研究提出抗衰老疗法的新思路</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/UQjHuNkoDuhzfXjCPae8Mw</id>
    <link href="https://mp.weixin.qq.com/s/UQjHuNkoDuhzfXjCPae8Mw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Moderna新冠候选疫苗保护力达94.5%，可使用现有冷藏设备储存和运送</title>
    <updated>2020-11-17T07:50:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/MUsGR-s6ENRecV4p7wfMTA</id>
    <link href="https://mp.weixin.qq.com/s/MUsGR-s6ENRecV4p7wfMTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ASH | 百济神州、和黄医药、亚盛医药、诺诚健华等创新产品即将亮相</title>
    <updated>2020-11-17T07:50:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/qxxutSFMtAWbtIqrQErH2w</id>
    <link href="https://mp.weixin.qq.com/s/qxxutSFMtAWbtIqrQErH2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 停药后1年仍然显著抑制乙肝疾病活动，RNAi疗法公布最新结果</title>
    <updated>2020-11-17T07:50:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/zGwZHHTk-YEmEwpBGqzSOg</id>
    <link href="https://mp.weixin.qq.com/s/zGwZHHTk-YEmEwpBGqzSOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 治疗NASH，索马鲁肽组合疗法公布最新临床试验结果</title>
    <updated>2020-11-17T07:50:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/M_IFycjOqBBDa-0cSZAt_A</id>
    <link href="https://mp.weixin.qq.com/s/M_IFycjOqBBDa-0cSZAt_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 靶向双重炎症相关细胞因子通路，创新疗法获FDA突破性疗法认定</title>
    <updated>2020-11-17T07:50:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/aToBxW8woArmM6vfVY_mKQ</id>
    <link href="https://mp.weixin.qq.com/s/aToBxW8woArmM6vfVY_mKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武汉大学宋保亮团队《自然》发文，带来降低胆固醇的新思路</title>
    <updated>2020-11-17T07:50:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/dmGHXg4a1TvjUmWNLSrxEg</id>
    <link href="https://mp.weixin.qq.com/s/dmGHXg4a1TvjUmWNLSrxEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从“有意回避”变为“研发热点”，共价抑制剂如何革新小分子药物开发？</title>
    <updated>2020-11-16T07:08:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/WWZBS1CsJKIg_NfDNqo8XA</id>
    <link href="https://mp.weixin.qq.com/s/WWZBS1CsJKIg_NfDNqo8XA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺和诺德首席科学官：糖尿病“终极疗法”正在开发</title>
    <updated>2020-11-16T07:08:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/OYSwiN1jx_896yvB_ZpBTQ</id>
    <link href="https://mp.weixin.qq.com/s/OYSwiN1jx_896yvB_ZpBTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《自然》深度报道：全球新冠死亡率正在下降，原因是什么？</title>
    <updated>2020-11-16T07:08:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/oEdwtfM-Z2MGOudJf2OKYQ</id>
    <link href="https://mp.weixin.qq.com/s/oEdwtfM-Z2MGOudJf2OKYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首款全身性给药体内CRISPR疗法进入临床试验；Moderna新冠疫苗3期临床试验首次中期分析即将展开</title>
    <updated>2020-11-16T07:08:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/G0s2JMhVaMPQhWMCU5qruA</id>
    <link href="https://mp.weixin.qq.com/s/G0s2JMhVaMPQhWMCU5qruA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>孤儿药周报 | CD20单抗治疗罕见贫血，杜氏肌营养不良寡核苷酸疗法入围</title>
    <updated>2020-11-16T07:08:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/zp8OaSoaDpgKDKybc9gO3Q</id>
    <link href="https://mp.weixin.qq.com/s/zp8OaSoaDpgKDKybc9gO3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明日下午3点！支持中美双申临床项目的生物分析试验关注点——交叉验证和内标响应评估</title>
    <updated>2020-11-16T07:08:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/8NP-7_Dkb2-1asBHiozF_g</id>
    <link href="https://mp.weixin.qq.com/s/8NP-7_Dkb2-1asBHiozF_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Keytruda首次获批治疗三阴性乳腺癌，与化疗联用降低疾病进展风险35%</title>
    <updated>2020-11-14T07:57:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/ZwioEjic6MGjIVyR3kn41g</id>
    <link href="https://mp.weixin.qq.com/s/ZwioEjic6MGjIVyR3kn41g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罕见病专栏 | 一周罕闻药事（11.7-11.13）</title>
    <updated>2020-11-14T07:57:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/9LPJduDDOtu0UbkNFnlI1g</id>
    <link href="https://mp.weixin.qq.com/s/9LPJduDDOtu0UbkNFnlI1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>